Orange Book product · Generic (ANDA)
CIMETIDINE
CIMETIDINE
At a glance
Nov 12, 2024
Approved
Generic (ANDA)
Application
AB
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Nov 12, 2024
1 yr 7 mo ago
Today
Pharmaceutical detail
Active ingredient
CIMETIDINE
Strength
200MG
Dosage form
TABLET
Route
ORAL
TE code
AB
Application
ANDA 218997
Product number
001
Marketing status
RX
Reference listed drug (RLD)
No
Reference standard (RS)
No
Active-ingredient family
View full familyGeneric (ANDA) of CIMETIDINE
- 1999TAGAMET HB 200Brand (NDA)
NDA 020951 · GLAXOSMITHKLINE
- 1995TAGAMET HBBrand (NDA)
NDA 020238 · MEDTECH PRODUCTS
- —TAGAMETBrand (NDA)
NDA 017920 · GLAXOSMITHKLINE
- 2024CIMETIDINEGeneric (ANDA)
ANDA 218220 · BIONPHARMA
- 1999CIMETIDINEGeneric (ANDA)
ANDA 075425 · WATSON LABS TEVA
- 1999CIMETIDINEGeneric (ANDA)
ANDA 075345 · IVAX SUB TEVA PHARMS
- 1998CIMETIDINEGeneric (ANDA)
ANDA 074890 · HIKMA
- 1998CIMETIDINEGeneric (ANDA)
ANDA 075285 · L PERRIGO CO
- 1998CIMETIDINEGeneric (ANDA)
ANDA 074948 · APOTEX
- 1998CIMETIDINEGeneric (ANDA)
ANDA 074961 · CONTRACT PHARMACAL
- 1998CIMETIDINEGeneric (ANDA)
ANDA 074963 · CONTRACT PHARMACAL
- 1998CIMETIDINEGeneric (ANDA)
ANDA 074972 · PERRIGO
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
